Nano CAST™ AI fully automated liquid biopsy system is the world’s first cancer detection platform integrating semiconductor biochips with AI automation. With 16mL of blood, it isolates intact circulating tumor cells, achieving over 90% capture efficiency and up to 90% sensitivity. By automating cell capture, staining, and AI imaging recognition, it reduces manual labor by 60% and delivers results within hours. Already applied in hospitals, Nano CAST™ helping doctors to detect cancer earlier, monitor treatment response, and track recurrence. For patients, it offers a simple, non-invasive test that reduces medical burden and improves access to precision cancer care, helping more people stay healthier, longer.